© 2019 by DESIGNMEDIX, INC.

Publications

____________________________________________________________________________________________________________________________

Gunsaru B, Burgess SJ, Morrill W, Kelly J, Shomloo S, Smilkstein M, Liebman K, Peyton DH: Simplified Reversed Chloroquines To Overcome Malaria Resistance to Quinoline-Based Drugs. Antimicrob. Agents Chemother. 2017, 61(5): e01913-16.

Wirjanata G, Sebayang BF, Chalfein F, Prayoga, Handayuni I, Noviyanti R, Kenangalem E, Poespoprodjo JR, Burgess SJ, Peyton DH, Price RN, Marfurt J: Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates. Antimicrob. Agents Chemother. 2015, 59(9): 5721-6.

Peyton, DH: Reversed chloroquine molecules as a strategy to overcome resistance in malaria. Curr. Top. Med. Chem. 2012, 12(5): 400-7.

Burgess, SJ; Kelly, JX; Shomloo, S; Wittlin, S; Brun, R; Liebmann, K; Peyton, DH: Synthesis, Structure-Activity Relationship, and Mode-of-Action Studies of Antimalarial Reversed Chloroquine Compounds. J. Med. Chem. 2010, 53(17): 6477-6489.

Burgess SJ, Selzer A, Kelly JX, Smilkstein MJ, Riscoe MK, Peyton DH: A Chloroquine-like Molecule Designed to Reverse Resistance in Plasmodium falciparum. J. Med. Chem.2006, 49(18):5623-5625.